167 related articles for article (PubMed ID: 9006866)
1. Marek's disease vaccination of chickens.
Outteridge P
Aust Vet J; 1996 Dec; 74(6):464. PubMed ID: 9006866
[No Abstract] [Full Text] [Related]
2. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
Bacon LD; Witter RL
Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of Marek's disease using 3 vaccines in chickens belonging to different genetic varieties of meat producers].
Picault JP; Guittet M; Bennejean G; Goater E
Dev Biol Stand; 1982; 52():447-53. PubMed ID: 6299854
[No Abstract] [Full Text] [Related]
4. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
6. Nonprotective and temperature-sensitive variants of Marek's disease vaccine viruses.
Witter RL; Offenbecker L
J Natl Cancer Inst; 1979 Jan; 62(1):143-51. PubMed ID: 214607
[No Abstract] [Full Text] [Related]
7. B haplotype influence on the relative efficacy of Marek's disease vaccines in commercial chickens.
Bacon LD; Witter RL
Poult Sci; 1994 Apr; 73(4):481-7. PubMed ID: 8202426
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the virus content per vaccination dose on the effectiveness of the immune prevention of Marek's disease in general practice].
Werner P; Werner O; Schmidt U; Sulk I; Reinhold P; Grünert G; Walter I; Härtling D; Jendreykow M; Exner H
Arch Exp Veterinarmed; 1985 Sep; 39(5):746-59. PubMed ID: 3000310
[No Abstract] [Full Text] [Related]
9. Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus.
Eidson CS; Page RK; Kleven SH
Avian Dis; 1978; 22(4):583-97. PubMed ID: 219826
[No Abstract] [Full Text] [Related]
10. [Immunological aspects of Marek's disease in poultry].
Leshnik F; Smeĭkalova E; Iurchina A; Konrad V; Vrtiak OIa
Arch Exp Veterinarmed; 1986 May; 40(3):393-8. PubMed ID: 3017267
[No Abstract] [Full Text] [Related]
11. Polyvalent recombinant Marek's disease virus vaccine against poultry diseases.
Hirai K; Sakaguchi M
Curr Top Microbiol Immunol; 2001; 255():261-87. PubMed ID: 11217427
[No Abstract] [Full Text] [Related]
12. Immunity to Marek's disease: where are we now?
Haq K; Schat KA; Sharif S
Dev Comp Immunol; 2013 Nov; 41(3):439-46. PubMed ID: 23588041
[TBL] [Abstract][Full Text] [Related]
13. [Effects of blood group markers (B allele), immunoglobulins and leukosis infections on the development of Marek's disease].
Löliger HC; von dem Hagen D; Krieg R
Dtsch Tierarztl Wochenschr; 1986 Jan; 93(1):44-9. PubMed ID: 3009129
[No Abstract] [Full Text] [Related]
14. Enhanced pathogenicity of chicken anemia agent by infectious bursal disease virus relative to the occurrence of Marek's disease vaccination breaks.
Otaki Y; Nunoya T; Tajima M; Saito K; Nomura Y
Nihon Juigaku Zasshi; 1989 Aug; 51(4):849-52. PubMed ID: 2555622
[No Abstract] [Full Text] [Related]
15. Marek's disease vaccines: Current status, and strategies for improvement and development of vector vaccines.
Reddy SM; Izumiya Y; Lupiani B
Vet Microbiol; 2017 Jul; 206():113-120. PubMed ID: 28038868
[TBL] [Abstract][Full Text] [Related]
16. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
Baigent SJ; Smith LP; Nair VK; Currie RJ
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
[TBL] [Abstract][Full Text] [Related]
17. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.
Sonoda K; Sakaguchi M; Okamura H; Yokogawa K; Tokunaga E; Tokiyoshi S; Kawaguchi Y; Hirai K
J Virol; 2000 Apr; 74(7):3217-26. PubMed ID: 10708438
[TBL] [Abstract][Full Text] [Related]
18. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
[TBL] [Abstract][Full Text] [Related]
19. [Immunogenic activity of vaccines against Marek's disease].
Persov AS; Korovin RN; Lokh VA; Aĭrapetov RG; Matiushkov VS
Veterinariia; 1978 Jul; (7):41-2. PubMed ID: 210559
[No Abstract] [Full Text] [Related]
20. Precipitating antibody development in chicks experimentally infected with herpes virus of turkey and Marek's disease virus.
Rana UV; Negi SK
J Commun Dis; 1986 Mar; 18(1):13-6. PubMed ID: 3018071
[No Abstract] [Full Text] [Related]
[Next] [New Search]
